Metabolic syndrome in obese adolescents is associated with risk for nephrolithiasis. 2012

Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
Department of Pediatrics, Baystate Medical Center/Tufts University School of Medicine, Boston, MA, USA.

OBJECTIVE To examine the relationship between urinary pH and metabolic syndrome risk factors along with insulin resistance in obese adolescents, and to evaluate the relationship between other urinary stone-forming and -inhibiting markers and metabolic syndrome. METHODS A total of 46 obese adolescents were enrolled. Twenty-four hour and randomly obtained urine samples were analyzed for urinary pH, promoters of stone formation (ie, uric acid, oxalate, and relative saturation ratio of calcium oxalate [RSR-CaOx]), and inhibitors of stone formation (ie, citrate and osteopontin). Other data collected included height, weight, blood pressure, and fasting lipid, insulin, and glucose levels. RESULTS The subjects had a mean age of 14.6±2.0 years and a mean body mass index of 36±6.3 kg/m(2). Random urine pH and the number of risk factors for metabolic syndrome were negatively correlated (r=-0.34; P=.02). RSR-CaOx was correlated with both homeostasis model assessment of insulin resistance score (r=0.38; P<.01) and number of risk factors for metabolic syndrome (r=0.47; P=.001) CONCLUSIONS Decreased urinary pH and increased RSR-CaOx are associated with risk factors for metabolic syndrome in obese adolescents.

UI MeSH Term Description Entries
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D053040 Nephrolithiasis Formation of stones in the KIDNEY.
D024821 Metabolic Syndrome A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. Cardiometabolic Syndrome,Insulin Resistance Syndrome X,Metabolic Syndrome X,Reaven Syndrome X,Dysmetabolic Syndrome X,Metabolic Cardiovascular Syndrome,Metabolic X Syndrome,Syndrome X, Insulin Resistance,Syndrome X, Metabolic,Cardiometabolic Syndromes,Cardiovascular Syndrome, Metabolic,Cardiovascular Syndromes, Metabolic,Metabolic Syndromes,Syndrome X, Dysmetabolic,Syndrome X, Reaven,Syndrome, Cardiometabolic,Syndrome, Metabolic,Syndrome, Metabolic Cardiovascular,Syndrome, Metabolic X,Syndromes, Cardiometabolic,Syndromes, Metabolic,X Syndrome, Metabolic

Related Publications

Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
December 2015, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine,
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
January 2013, Revista da Associacao Medica Brasileira (1992),
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
January 2021, Frontiers in pediatrics,
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
February 2013, European journal of pediatrics,
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
February 2010, Pediatric diabetes,
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
January 2013, Nutrition journal,
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
June 2012, Journal of pediatric gastroenterology and nutrition,
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
January 2009, International journal of obesity (2005),
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
January 2015, Srpski arhiv za celokupno lekarstvo,
Rishita Tiwari, and Thomas Campfield, and Chrystal Wittcopp, and Gregory Braden, and Paul Visintainer, and Edward O Reiter, and Holley F Allen
January 2014, Gene,
Copied contents to your clipboard!